J Appl Biomed 12:291-299, 2014 | DOI: 10.1016/j.jab.2014.03.001
Possible hepatocellular toxicity of EGCG under the influence of an inflammagen
- a National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS 38677, USA
- b Department of Pharmacology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt
- c Department of Pharmacology, School of Pharmacy, University of Mississippi, University, MS 38677, USA
- d Department of Pharmacognosy, School of Pharmacy, University of Mississippi, University, MS 38677, USA
- e Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11557, Saudi Arabia
Epigallocatechin-3-gallate (EGCG) is widely used as a weight controlling supplement. Concerns about its safety evoked after cases of hepatotoxicity occurred upon its use. The underlying factors that could be involved in EGCG associated hepatotoxicity are not fully studied. In this study, we investigated the possible impact of lipopolysaccharide (LPS), as an inflammagen, on the effect of EGCG on hepatocytes. HepG2 cells were treated with different concentrations of EGCG (100, 200, 500 μM), with and without LPS (10 nM)-presensitization of the cells. Viability of HepG2 cells decreased with the increased concentrations of EGCG; the viability was even lesser in LPS-presensitized cells. Oxidative stress (Ox.LDL and CXCL16), the expression of nuclear retinoic receptors (RAR, RXR) and the biomarkers of hepatocellular injury (TNFα, TGFβ1) were all relatively higher in LPS-presensitized cells compared to non-sensitized cells upon treatment with EGCG. Sensitization of HepG2 cells with LPS alone did not affect the viability or any of the other biomarkers considered in this study. In conclusion, EGCG alone can be harmful to liver at high concentrations and this effect may become more pronounced under the influence of an inflammagen.
Keywords: Green tea; EGCG; LPS; Inflammation; Hepatotoxicity
Received: December 27, 2013; Revised: February 28, 2014; Accepted: March 17, 2014; Published: November 1, 2014 Show citation
References
- Abdel-Bakky, M., Hammad, M., Walker, L., Ashfaq, M., 2010a. Loss of retinoic acid receptor (RAR) and retinoid X receptor (RXR) contribute to liver toxicity in MCT/LPS co-treated mice model. Planta Med. 76, P100.
Go to original source...
- Abdel-Bakky, M.S., Hammad, M.A., Walkerit, L., Ashfaqi, M., 2010b. Developing and characterizing a mouse model of hepatotoxicity using oral pyrrolizidine alkaloid (monocrotaline) administration, with potentiation of the liver injury by co-administration of LPS. Nat. Prod. Commun. 5, 1457-1462.
Go to original source...
Go to PubMed...
- Amengual, J., Petrov, P., Bonet, M.L., Ribot, J., Palou, A., 2012. Induction of carnitine palmitoyl transferase 1 and fatty acid oxidation by retinoic acid in HepG2 cells. Int. J. Biochem. Cell Biol. 44, 2019-2027.
Go to original source...
Go to PubMed...
- Bahcecioglu, I.H., Yalniz, M., Ataseven, H., Bulbuller, N., Kececi, M., Demirdag, K., Ozercan, I., Ustundag, B., 2004. TNF-alpha and leptin in experimental liver fibrosis models induced by carbon tetrachloride and by common bile duct ligation. Cell Biochem. Funct. 22, 359-363.
Go to original source...
Go to PubMed...
- Barlic, J., Zhang, Y., Murphy, P.M., 2007. Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFalpha-NFkappaB-dependent manner. J. Biol. Chem. 282, 19167-19176.
Go to original source...
Go to PubMed...
- Blaner, W.S., O'Byrne, S.M., Wongsiriroj, N., Kluwe, J., D'Ambrosio, D.M., Jiang, H., Schwabe, R.F., Hillman, E.M., Piantedosi, R., Libien, J., 2009. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim. Biophys. Acta 6, 467-473.
Go to original source...
Go to PubMed...
- Cabrera, C., Artacho, R., Giménez, R., 2006. Beneficial effects of green tea-a review. J. Am. Coll. Nutr. 25, 79-99.
Go to original source...
Go to PubMed...
- Fan, Y.C., Chan, W.H., 2013. Epigallocatechin gallate induces embryonic toxicity in mouse blastocysts through apoptosis. Drug Chem. Toxicol. 28, 28.
Go to original source...
Go to PubMed...
- Gao, H.T., Xu, L.S., Li, D.F., Guang, L.C., Deng, W.P., 2013. Effects of glucagon-like peptide-1 on liver oxidative stress, TNFalpha and TGF-beta1 in rats with non-alcoholic fatty liver disease. Nan Fang Yi Ke Da Xue Xue Bao 33, 1661-1664.
Go to PubMed...
- Gressner, A., Weiskirchen, R., 2006. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-b as major players and therapeutic targets. J. Cell Mol. Med. 10, 76-99.
Go to original source...
Go to PubMed...
- Gressner, A.M., Weiskirchen, R., Breitkopf, K., Dooley, S., 2002. Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 7, d793-d807.
Go to original source...
Go to PubMed...
- Gutwein, P., Abdel-Bakky, M.S., Doberstein, K., Schramme, A., Beckmann, J., Schaefer, L., Amann, K., Doller, A., KampferKolb, N., Abdel-Aziz, A.A., El Sayed el, S.M., Pfeilschifter, J., 2009. CXCL16 and Ox.LDL are induced in the onset of diabetic nephropathy. J. Cell Mol. Med. 13, 3809-3825.
Go to original source...
Go to PubMed...
- Hammam, O., Mahmoud, O., Zahran, M., Sayed, A., Salama, R., Hosny, K., Farghly, A., 2013. A possible role for TNF-alpha in coordinating inflammation and angiogenesis in chronic liver disease and hepatocellular carcinoma. Gastrointest. Cancer Res. 6, 107-114.
- Hirsova, P., Karlasova, G., Dolezelova, E., Cermanova, J., Zagorova, M., Kadova, Z., Hroch, M., Sispera, L., Tomsik, P., Lenicek, M., Vitek, L., Pavek, P., Kucera, O., Cervinkova, Z., Micuda, S., 2013. Cholestatic effect of epigallocatechin gallate in rats is mediated via decreased expression of Mrp2. Toxicology 303, 9-15.
Go to original source...
Go to PubMed...
- Holmoy, T., Loken-Amsrud, K.I., Bakke, S.J., Beiske, A.G., Bjerve, K.S., Hovdal, H., Lilleas, F., Midgard, R., Pedersen, T., Saltyte Benth, J., Torkildsen, O., Wergeland, S., Myhr, K.M., Michelsen, A.E., Aukrust, P., Ueland, T., 2013. Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity. PLoS ONE 8, 0075021.
Go to original source...
- Hursel, R., Westerterp-Plantenga, M.S., 2013. Catechin- and caffeine-rich teas for control of body weight in humans. Am. J. Clin. Nutr. 98, 30.
Go to original source...
Go to PubMed...
- Isbrucker, R., Edwards, J., Wolz, E., Davidovich, A., Bausch, J., 2006. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. Food Chem. Toxicol. 44, 636-650.
Go to original source...
Go to PubMed...
- Kajdaniuk, D., Marek, B., Borgiel-Marek, H., Kos-Kudla, B., 2013. Transforming growth factor beta1 (TGFbeta1) in physiology and pathology. Endokrynol. Pol. 64, 384-396.
Go to original source...
Go to PubMed...
- Kanzler, S., Lohse, A.W., Keil, A., Henninger, J., Dienes, H.P., Schirmacher, P., Rose-John, S., Meyer Zum Büschenfelde, K.H., Blessing, M., 1999. TGF-b1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 276, G1059-G1068.
Go to original source...
Go to PubMed...
- Lambert, J.D., Kennett, M.J., Sang, S., Reuhl, K.R., Ju, J., Yang, C.S., 2010. Hepatotoxicity of high oral dose (Agrave)-epigallocatechin-3gallate in mice. Food Chem. Toxicol. 48, 409-416.
Go to original source...
Go to PubMed...
- Lenich, C.M., Ross, A.C., 1987. Chylomicron remnant-vitamin A metabolism by the human hepatoma cell line HepG2. J. Lipid Res. 28, 183-194.
Go to original source...
Go to PubMed...
- Ma, Y.Y., Li, L., Yu, C.H., Shen, Z., Chen, L.H., Li, Y.M., 2013. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J. Gastroenterol. 19, 6911-6918.
Go to original source...
Go to PubMed...
- Mahajna, J., Shi, B., Bruskin, A., 1997. A four-amino-acid insertion in the ligand-binding domain inactivates hRXRbeta and renders dominant negative activity. DNA Cell Biol. 16, 463-476.
Go to original source...
Go to PubMed...
- Matsuzaki, K., Seki, T., Okazaki, K., 2013. TGF-beta signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases. J. Gastroenterol. 22, 22.
Go to original source...
Go to PubMed...
- Maziere, C., Meignotte, A., Dantin, F., Conte, M.A., Maziere, J.C., 2000. Oxidized LDL induces an oxidative stress and activates the tumor suppressor p53 in MRC5 human fibroblasts. Biochem. Biophys. Res. Commun. 276, 718-723.
Go to original source...
Go to PubMed...
- Mazzanti, G., Menniti-Ippolito, F., Moro, P.A., Cassetti, F., Raschetti, R., Santuccio, C., Mastrangelo, S., 2009. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur. J. Clin. Pharmacol. 65, 331-341.
Go to original source...
Go to PubMed...
- Medzhitov, R., 2008. Origin and physiological roles of inflammation. Nature 454, 428-435.
Go to original source...
Go to PubMed...
- Neuman, M.G., Schmilovitz-Weiss, H., Hilzenrat, N., Bourliere, M., Marcellin, P., Trepo, C., Mazulli, T., Moussa, G., Patel, A., Baig, A.A., Cohen, L., 2012. Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C. Int. J. Hepatol. 231210, 22.
Go to original source...
Go to PubMed...
- Nosadini, R., Tonolo, G., 2011. Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes. Nutr. Metab. Cardiovasc. Dis. 21, 79-85.
Go to original source...
Go to PubMed...
- Oh, S.T., Schramme, A., Tilgen, W., Gutwein, P., Reichrath, J., 2009. Overexpression of CXCL16 in lesional psoriatic skin. Dermatoendocrinology 1, 114-118.
Go to original source...
Go to PubMed...
- Sakata, K., Hara, M., Terada, T., Watanabe, N., Takaya, D., Yaguchi, S., Matsumoto, T., Matsuura, T., Shirouzu, M., Yokoyama, S., Yamaguchi, T., Miyazawa, K., Aizaki, H., Suzuki, T., Wakita, T., Imoto, M., Kojima, S., 2013. HCV NS3 protease enhances liver fibrosis via binding to and activating TGF-beta type I receptor. Sci. Rep. 3.
Go to original source...
- Saleh, I., Ali, Z., Hamada, F., Abd-Ellah, M., Khan, I., Walker, L., Ashfaq, M., 2013a. Consumption of EGCG can become hepatotoxic under inflammatory condition. Planta Med. 79, P95.
Go to original source...
- Saleh, I.G., Ali, Z., Abe, N., Wilson, F.D., Hamada, F.M., Abd-Ellah, M.F., Walker, L.A., Khan, I.A., Ashfaq, M.K., 2013b. Effect of green tea and its polyphenols on mouse liver. Fitoterapia 90, 151-159.
Go to original source...
Go to PubMed...
- Saleh, I.G., Ali, Z., Hamada, F.M., Abd-Ellah, M.F., Walker, L.A., Khan, I.A., Ashfaq, M.K., 2013c. Effect of green tea on hepatic cells under the influence of inflammatory conditions: in vitro study. Am. J. Pharmacol. Toxicol. 8, 209.
Go to original source...
- Sarma, D.N., Barrett, M.L., Chavez, M.L., Gardiner, P., Ko, R., Mahady, G.B., Marles, R.J., Pellicore, L.S., Giancaspro, G.I., Low Dog, T., 2008. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf. 31, 469-484.
Go to original source...
Go to PubMed...
- Shaw, P.J., Ditewig, A.C., Waring, J.F., Liguori, M.J., Blomme, E.A., Ganey, P.E., Roth, R.A., 2009. Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury. Toxicol. Sci. 107, 270-280.
Go to original source...
Go to PubMed...
- Shiota, G., Kanki, K., 2013. Retinoids and their target genes in liver functions and diseases. J. Gastroenterol. Hepatol. 1, 33-37.
Go to original source...
Go to PubMed...
- Silva, K.C., Rosales, M.A., Hamassaki, D.E., Saito, K.C., Faria, A. M., Ribeiro, P.A., Faria, J.B., Faria, J.M., 2013. Green tea is neuroprotective in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 54, 1325-1336.
Go to original source...
Go to PubMed...
- Starkel, P., Sempoux, C., Leclercq, I., Herin, M., Deby, C., Desager, J.P., Horsmans, Y., 2003. Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J. Hepatol. 39, 538-546.
Go to original source...
Go to PubMed...
- Su, G.L., Gong, K.Q., Fan, M.H., Kelley, W.M., Hsieh, J., Sun, J.M., Hemmila, M.R., Arbabi, S., Remick, D.G., Wang, S.C., 2005. Lipopolysaccharide-binding protein modulates acetaminophen-induced liver injury in mice. Hepatology 41, 187-195.
Go to original source...
Go to PubMed...
- Xu, H.-B., Gong, Y.-P., Cheng, J., Chu, Y.-W., Xiong, S.-D., 2005. CXCL16 participates in pathogenesis of immunological liver injury by regulating T lymphocyte infiltration in liver tissue. World J. Gastroenterol. 11, 4979.
Go to original source...
Go to PubMed...
- Yin, Y., Liu, W., Ji, G., Dai, Y., 2013. The essential role of p38 MAPK in mediating the interplay of Ox.LDL and IL-10 in regulating endothelial cell apoptosis. Eur. J. Cell Biol. 92, 150-159.
Go to original source...
Go to PubMed...